Rab 2A Activators
The chemical class termed Rab 2A Activators encompasses a range of compounds that are hypothesized to indirectly influence the Rab 2A protein and its associated pathways. These compounds primarily operate by affecting various aspects of vesicle trafficking, cytoskeletal dynamics, and cellular signaling, which are critical for the functions where Rab 2A is involved. Compounds like Forskolin, Brefeldin A, Monensin, and Nocodazole influence intracellular transport and cytoskeletal dynamics. Forskolin, through elevating cAMP levels, and Brefeldin A and Monensin, by disrupting Golgi structure and function, could indirectly modulate Rab 2A activity in vesicle formation and trafficking. Nocodazole's effect on microtubule polymerization offers another route through which Rab 2A's role in vesicle transport might be influenced.
Additionally, Wiskostatin, Cytochalasin D, and Jasplakinolide, which affect the actin cytoskeleton, provide insight into how Rab 2A activity could be indirectly influenced in the context of vesicle movement. The modulation of the cytoskeletal network is crucial for vesicle transport and positioning within the cell.Furthermore, Okadaic acid and ML141, through their roles in modulating phosphorylation states and Cdc42 activity, respectively, could impact Rab 2A activity. Okadaic acid's influence on phosphorylation states and ML141's inhibition of Cdc42 can indirectly affect the molecular interactions and dynamics critical for vesicle trafficking.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases cAMP levels, potentially influencing pathways that intersect with Rab 2A, particularly those related to vesicle formation and trafficking. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Known to disrupt Golgi structure and function, which could influence Rab 2A activity indirectly by altering vesicle trafficking pathways. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Affects intracellular transport and Golgi apparatus function, potentially impacting Rab 2A activity in vesicle trafficking. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Disrupts microtubule polymerization, potentially affecting Rab 2A's role in vesicle transport along microtubules. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Inhibits N-WASP, affecting cytoskeletal dynamics and potentially Rab 2A activity in vesicle trafficking processes. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Disrupts actin filaments, potentially influencing Rab 2A activity by altering the cytoskeletal network involved in vesicle movement. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
A phosphatase inhibitor, could indirectly affect Rab 2A activity by altering phosphorylation states of proteins involved in vesicle trafficking. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
A Cdc42 inhibitor, could impact Rab 2A indirectly through the modulation of actin cytoskeleton dynamics and vesicle trafficking. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $191.00 $683.00 | 11 | |
Specific inhibitor of the Golgi BFA resistance factor 1 (GBF1), could indirectly affect Rab 2A by altering Golgi apparatus function and vesicle trafficking. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Stabilizes actin filaments, potentially influencing Rab 2A activity by affecting the actin cytoskeleton which is involved in vesicle movement. | ||||||